N-[(2R,8S,11S,14S,17S,20R,21S)-2-benzyl-14-[(1R)-1-hydroxy-2-methylpropyl]-17-[(1R)-1-methoxyethyl]-4,8,10,11,16,20-hexamethyl-5-methylidene-3,6,9,12,15,18,22-heptaoxo-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-21-yl]acetamide

Term ID

CHEBI:203966

Synonyms

N-[(2R,8S,11S,14S,17S,20R,21S)-2-benzyl-14-[(1R)-1-hydroxy-2-methylpropyl]-17-[(1R)-1-methoxyethyl]-4,8,10,11,16,20-hexamethyl-5-methylidene-3,6,9,12,15,18,22-heptaoxo-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-21-yl]acetamide

Definition

References

Chemspider:9506725

Ontology

ChEBI ( EBI )

Relationships

is a type of: cyclodepsipeptide

cyclodepsipeptide Show first 5 Terms

Phenotype

Phenotype resulting from N-[(2R,8S,11S,14S,17S,20R,21S)-2-benzyl-14-[(1R)-1-hydroxy-2-methylpropyl]-17-[(1R)-1-methoxyethyl]-4,8,10,11,16,20-hexamethyl-5-methylidene-3,6,9,12,15,18,22-heptaoxo-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-21-yl]acetamide

Phenotype where environments contain N-[(2R,8S,11S,14S,17S,20R,21S)-2-benzyl-14-[(1R)-1-hydroxy-2-methylpropyl]-17-[(1R)-1-methoxyethyl]-4,8,10,11,16,20-hexamethyl-5-methylidene-3,6,9,12,15,18,22-heptaoxo-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-21-yl]acetamide

Phenotype modified by environments containing N-[(2R,8S,11S,14S,17S,20R,21S)-2-benzyl-14-[(1R)-1-hydroxy-2-methylpropyl]-17-[(1R)-1-methoxyethyl]-4,8,10,11,16,20-hexamethyl-5-methylidene-3,6,9,12,15,18,22-heptaoxo-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-21-yl]acetamide

Human Disease Model